| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Rob Gronkowski, three-time Super Bowl champion with the NFL’s New England Patriots, is the latest athlete to enter the CBD market. The five-time Pro Bowler has agreed to support current and future CBD items from Abacus Health Products, Inc. (CSE:ABCS).
Gronk will be tasked with helping increase brand awareness through marketing and product development.
Awareness efforts are slated to increase in 2020 with what the company calls a “Gronk-inspired” line of nutrition and wellness products. Abacus called Gronkowski an “excellent fit” for the 2020 line, which aims to mark the company’s entrance into the ingestible CBD space.
Perry Antelman, Abacus CEO, explained why the NFL vet fit with the brand.
“Gronk’s passion for living life to the fullest while maintaining a healthy, natural, and pain-free lifestyle aligns perfectly with the mission of our company," he said.
Gronkowski, who underwent nine surgeries during his NFL career, said, "These products have helped me safely manage pain better than anything else I’ve tried. I’m inspired to work with the company to introduce new CBD products to the market."
Related Links:
Calvin Johnson's Cannabis Company To Partner With Harvard On CTE, Pain Studies
Eaze Announces CBD Line For Athletes, Partnership With Celtics Legend Paul Pierce
Posted In: CSE:ABCS
